Abacavir, dolutegravir, and lamivudine and Lenvatinib Mesylate
Determining the interaction of Abacavir, dolutegravir, and lamivudine and Lenvatinib Mesylate and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: abacavir / dolutegravir / lamivudine
Brand name: Triumeq
Synonyms: Abacavir, Dolutegravir, and Lamivudine
Generic Name: lenvatinib
Brand name: Lenvima, Lenvima 8 mg daily-dose, Lenvima 20 mg daily-dose, Lenvima 12 mg daily-dose
Synonyms: Lenvatinib
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Abacavir, dolutegravir, and lamivudine-Lenvima
- Abacavir, dolutegravir, and lamivudine-Lenvima (14 MG Daily Dose)
- Abacavir, dolutegravir, and lamivudine-Lenvima (18 MG Daily Dose)
- Abacavir, dolutegravir, and lamivudine-Lenvima (20 MG Daily Dose)
- Abacavir, dolutegravir, and lamivudine-Lenvima (24 MG Daily Dose)
- Abacavir, dolutegravir, and lamivudine-Lenvima (8 MG Daily Dose)
- Lenvatinib Mesylate-Abacavir, Lamivudine and Zidovudine Tablets
- Lenvatinib Mesylate-Abacavir, lamivudine, and zidovudine
- Lenvatinib Mesylate-Abaloparatide
- Lenvatinib Mesylate-Abaloparatide Subcutaneous
- Lenvatinib Mesylate-Abatacept
- Lenvatinib Mesylate-Abatacept Auto-Injectors